- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05419791
The Effects of Lokomat Virtual Reality Applications on Balance and Gait in Stroke Patients
Study Overview
Status
Conditions
Detailed Description
Stroke is an important health problem worldwide. Emotional, cognitive, sensory and motor problems occur with stroke. Motor problems are especially balance and walking problems and they are related to each other. So balance and gait rehabilitation are primary goals in stroke.
Although the first study to support the efficacy of Lokomat is that Lokomat is superior to conventional physiotherapy in walking, there are also studies reporting that there is no difference between the effects of Lokomat and conventional physiotherapy and that conventional physiotherapy is superior. In the light of all these studies, the effectiveness of applying robotic systems together with conventional physiotherapy is widely accepted.
Robot Assisted Walking Training has many components such as guiding force, walking speed, body weight support. Virtual reality is one of these components and there is literature in which Lokomat virtual reality applications are effective on balance and walking. Although the virtual reality effect is emphasized for Lokomat, there is a lack of literature on the specific effect of different virtual reality applications. In our study, it was aimed to examine the changes caused by different Lokomat virtual reality applications in the spatiotemporal parameters of balance and gait.
Method: This study was conducted to examine the effects of Lokomat VR applications on balance and spatiotemporal parameters of gait in patients with chronic stroke; It is a prospective, randomized controlled, single-blind study. The study will be carried out in a single-blind manner, and the evaluator will not know which group the individual is in. 56 individuals with chronic stroke included our study. All individuals have been informed about the study and read and signed the consent form stating that they voluntarily participated in the study. For balance evaluation we used Berg Balance Scale and Huber 360 device, which measures postural stability and limits of stability. And for gait evaluation we used 10 MWT, 6 MWT and spatiotemporal gait analysis for C-Mill VR+.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06000
- Ankara City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis is stroke
- The time period have to be chronic period (+6 months)
- The patient must have the ability to walk with or without support
- The patiens should be able to understand Lokomat exercises
Exclusion Criteria:
- Any condition that may prevent walking with Lokomat
- Not volunteering to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lokomat Group I (Endurance)
|
-Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
|
|
Experimental: Lokomat Group II (Attention and Motivation)
|
-Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
|
|
Experimental: Lokomat Group III (Activity Timing)
|
-Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
|
|
Other: Control
-Only Conventional Physiotherapy
|
-Conventional Physiotherapy : 5 days in a week for 6 weeks, every seanson was 40 min.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in 6 MWT
Time Frame: 6 weeks after treatment
|
6 Minutes Walk Test is a test using for walking distance.
We evaluated the change in walking distance with 6 MWT.
|
6 weeks after treatment
|
|
Change in 10 MWT
Time Frame: 6 weeks after treatment
|
10 MWT is a test using for evaluate the gait speed.
Gait speed is a spatiotemporal parameter.
|
6 weeks after treatment
|
|
Change in BBS
Time Frame: 6 weeks after treatment
|
Berg Balance Scale used for balance assesment.
The scale consists of 14 items and each item gets a score between 0-4.
As a result, the person evaluated gets a score between 0-56 on the berg balance scale.
A higher score means the person has better balance skills.
|
6 weeks after treatment
|
|
Change in Limits of Stability
Time Frame: 6 weeks after treatment
|
Limits of Stability (LoS) are defined as the points at which the center of gravity (CoG) approaches the limits of the base of support (BoS) and a correction strategy is required to return the center of mass (CoM) to within the BoS.
In other words, LoS is the amount of maximum excursion an individual is able to intentionally cover in any direction without losing his/her balance or taking a step.
We used Huber 360 device to evaluate the LoS.
|
6 weeks after treatment
|
|
Change in Spatiotemporal Gait Analysis
Time Frame: 6 weeks after treatment
|
Spatiotemporal gait analysis gives spatial (distance) parameters along with temporal (time) parameters.
|
6 weeks after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Spatial Symmetry
Time Frame: 6 weeks after treatment
|
It is the ratio of the hemiplegic side step lenght to the non-hemiplegic side step lenght.
|
6 weeks after treatment
|
|
Change in Temporal Symmetry
Time Frame: 6 weeks after treatment
|
For temporal symmetry we used the description "Gait Symmetry".
Gait symmetry is calculated by the ratio of the hemiplegic side sway phase to the hemiplegic side stance phase ratio and the ratio of the non-hemiplegic side sway phase to the non-hemiplegic side stance phase ratio.
|
6 weeks after treatment
|
|
Change in Postural Stability
Time Frame: 6 weeks after treatment
|
Postural stability refers to the ability to maintain your body in a position to effectively complete a task or demand, using large muscle groups at the shoulders, trunk, and hips.
We used Huber 360 device to evaluate the postural staiblity.
The assesments were combination of opened and closed eyes.
We recorded the COP vellocity and area.
|
6 weeks after treatment
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Lokomat VR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
Clinical Trials on Robot Asisted Gait Training with Lokomat (Endurance)
-
I.R.C.C.S. Fondazione Santa LuciaUniversity of Roma La SapienzaCompletedSpinal Cord InjuriesItaly
-
Cereneo AGUniversity of Zurich; Swiss Federal Institute of Technology; Swiss Commission... and other collaboratorsTerminatedPost Stroke Gait TrainingSwitzerland
-
Yeonji ChoiActive, not recruiting
-
Istanbul Arel UniversityKayseri UniversityNot yet recruiting
-
University of ZurichUnknownHeart Failure | Post Cardiac SurgerySwitzerland
-
Hangang Sacred Heart HospitalNational Research Foundation of KoreaNot yet recruitingPain | Burns | Virtual Reality
-
The University of Texas Medical Branch, GalvestonRecruitingStroke | Virtual Reality | Robot Assisted Gait TrainingUnited States
-
Hangang Sacred Heart HospitalRecruitingBurns | Rehabilitation | Gait TrainingKorea, Republic of
-
Yonsei UniversityRecruitingAcute Hemiplegic Stroke Including Subacute PhasesKorea, Republic of
-
Hangang Sacred Heart HospitalMinistry of Health, Republic of KoreaCompletedBurns | Gait Disorder, SensorimotorKorea, Republic of